See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2023_Vyant_Bio_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.06473988439306358, 'aggregate_val': 16578000, 'exp_sum': 15570000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 0, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 8798000, 'ResearchAndDevelopmentExpense': 6772000, 'remainder_Expenses': 0}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.19554520924818794, 'aggregate_val': 15205000, 'exp_sum': 18901000, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 3696000, 'AssetsCurrent': 11509000, 'PropertyPlantAndEquipment': 1106000, 'remainder_Assets': 2590000}} |
Graph
Absolute values for 0001349929, Vyant Bio Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 3,696,000 |
| 2 | AssetsCurrent | 11,509,000 |
| 3 | PropertyPlantAndEquipment | 1,106,000 |
| 4 | remainder_Assets | -1,106,000 |
| 5 | LongTermLiabilities | 1,358,000 |
| 6 | LiabilitiesCurrent | 3,665,000 |
| 7 | remainder_Liabilities | 273,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 8,798,000 |
| 15 | ResearchAndDevelopmentExpense | 6,772,000 |
| 16 | remainder_Expenses | 1,008,000 |
| 17 | remainder_Revenues | 666,000 |
| 18 | remainder_NetIncome | -6,778,000 |
| 19 | remainder_ComprehensiveNetIncome | 42,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 15,205,000 |
| 1 | Liabilities | 5,296,000 |
| 2 | Expenses | 16,578,000 |
| 3 | Revenues | 666,000 |
| 4 | StockholdersEquity | 9,909,000 |
| 5 | NetIncome | -22,690,000 |
| 6 | ComprehensiveNetIncome | -22,648,000 |
| 7 | BaseVar | 26,253,060 |
| 8 | EconomicCapitalRatio | -1.30 |
Edgar->Model Mapping
Feature Distribution
Change over Time
